Literature DB >> 16970885

Mental retardation and epilepsy in patients with isolated cerebellar hypoplasia.

Patrizia Ventura1, Anna Presicci, Tommaso Perniola, Maria Gloria Campa, Lucia Margari.   

Abstract

Congenital nonprogressive cerebellar ataxia includes a complex group of disorders with heterogeneous phenotypic and etiopathogenetic characteristics. Despite recent advances in the understanding of the role of the cerebellum in cognition and behavior, the opinion that the clinical presentation of congenital cerebellar diseases is principally linked to motor dysfunction is common. This is largely due to the lack of well-organized epidemiologic studies on the prevalence of nonmotor disturbances in cerebellar disease. The association between congenital cerebellar disease and epilepsy has rarely been described. We report clinical, neurophysiologic, neuroimaging, and neuropsychologic features in a group of 14 patients with congenital nonprogressive cerebellar ataxia associated with cerebellar hypoplasia, 5 of whom have familial disease, aiming to further a better knowledge of the prevalence of cognitive and/or emotional impairment and epilepsy. The results confirm that cerebellar hypoplasia predisposes individuals to psychomotor delay (71.4%) and cognitive impairment (85.7%). Moreover, the tendency toward abnormal electroencephalographic (EEG) findings (78.5%), associated in a minor percentage of cases with epilepsy (28.5%), is also evident in our study.

Entities:  

Mesh:

Year:  2006        PMID: 16970885     DOI: 10.1177/08830738060210091301

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

Review 1.  A Proposed Clinical Classification and a Diagnostic Approach for Congenital Ataxias.

Authors:  Ivana Rocha Raslan; Orlando G Barsottini; José Luiz Pedroso
Journal:  Neurol Clin Pract       Date:  2021-06

Review 2.  A developmental and genetic classification for midbrain-hindbrain malformations.

Authors:  A James Barkovich; Kathleen J Millen; William B Dobyns
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

3.  Mutation in NSUN2, which encodes an RNA methyltransferase, causes autosomal-recessive intellectual disability.

Authors:  Muzammil Ahmad Khan; Muhammad Arshad Rafiq; Abdul Noor; Shobbir Hussain; Joana V Flores; Verena Rupp; Akshita K Vincent; Roland Malli; Ghazanfar Ali; Falak Sher Khan; Gisele E Ishak; Dan Doherty; Rosanna Weksberg; Muhammad Ayub; Christian Windpassinger; Shahnaz Ibrahim; Michaela Frye; Muhammad Ansar; John B Vincent
Journal:  Am J Hum Genet       Date:  2012-04-26       Impact factor: 11.025

4.  GLUT2-mediated glucose uptake and availability are required for embryonic brain development in zebrafish.

Authors:  Rubén Marín-Juez; Mireia Rovira; Diego Crespo; Michiel van der Vaart; Herman P Spaink; Josep V Planas
Journal:  J Cereb Blood Flow Metab       Date:  2014-10-08       Impact factor: 6.200

5.  Cerebellar Agenesis and Bilateral Polimicrogyria Associated with Rare Variants of CUB and Sushi Multiple Domains 1 Gene (CSMD1): A Longitudinal Neuropsychological and Neuroradiological Case Study.

Authors:  Floriana Costanzo; Ginevra Zanni; Elisa Fucà; Margherita Di Paola; Sabina Barresi; Lorena Travaglini; Giovanna Stefania Colafati; Antonio Gambardella; Emanuele Bellacchio; Enrico Bertini; Deny Menghini; Stefano Vicari
Journal:  Int J Environ Res Public Health       Date:  2022-01-22       Impact factor: 3.390

6.  A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology.

Authors:  Leigh Paton; Emmanuelle Bitoun; Janet Kenyon; David A Priestman; Peter L Oliver; Benjamin Edwards; Frances M Platt; Kay E Davies
Journal:  J Biol Chem       Date:  2014-08-08       Impact factor: 5.157

7.  Further delineation of autosomal recessive intellectual disability syndrome caused by homozygous variant of the NSUN2 gene in a chinese pedigree.

Authors:  Songyang Sun; Lin Chen; Yuchuan Wang; Jian Wang; Niu Li; Xike Wang
Journal:  Mol Genet Genomic Med       Date:  2020-10-01       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.